NO20032371D0 - Makrolidsolvater - Google Patents

Makrolidsolvater

Info

Publication number
NO20032371D0
NO20032371D0 NO20032371A NO20032371A NO20032371D0 NO 20032371 D0 NO20032371 D0 NO 20032371D0 NO 20032371 A NO20032371 A NO 20032371A NO 20032371 A NO20032371 A NO 20032371A NO 20032371 D0 NO20032371 D0 NO 20032371D0
Authority
NO
Norway
Prior art keywords
makrolidsolvater
Prior art date
Application number
NO20032371A
Other languages
English (en)
Other versions
NO324951B1 (no
NO20032371L (no
Inventor
Victor Centellas
Jose Diago
Rafael Garcia
Johannes Ludescher
Original Assignee
Biochemie Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0031355A external-priority patent/GB0031355D0/en
Application filed by Biochemie Sa filed Critical Biochemie Sa
Publication of NO20032371D0 publication Critical patent/NO20032371D0/no
Publication of NO20032371L publication Critical patent/NO20032371L/no
Publication of NO324951B1 publication Critical patent/NO324951B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NO20032371A 2000-11-27 2003-05-26 Azitromycin og fremgangsmate for fremstilling derav NO324951B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25311900P 2000-11-27 2000-11-27
GB0031355A GB0031355D0 (en) 2000-12-21 2000-12-21 Organic compounds
PCT/EP2001/013760 WO2002042315A2 (en) 2000-11-27 2001-11-26 Macrolide solvates

Publications (3)

Publication Number Publication Date
NO20032371D0 true NO20032371D0 (no) 2003-05-26
NO20032371L NO20032371L (no) 2003-07-10
NO324951B1 NO324951B1 (no) 2008-01-14

Family

ID=26245472

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032371A NO324951B1 (no) 2000-11-27 2003-05-26 Azitromycin og fremgangsmate for fremstilling derav

Country Status (15)

Country Link
US (1) US6949519B2 (no)
EP (1) EP1339730A2 (no)
JP (1) JP2004519430A (no)
KR (1) KR100815163B1 (no)
AU (1) AU2002221895A1 (no)
BG (1) BG66200B1 (no)
CA (1) CA2429639C (no)
CZ (1) CZ303343B6 (no)
EE (1) EE05200B1 (no)
HR (1) HRP20030430B1 (no)
HU (1) HU229488B1 (no)
NO (1) NO324951B1 (no)
PL (1) PL207076B1 (no)
SK (1) SK287814B6 (no)
WO (1) WO2002042315A2 (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20020231A2 (en) 2002-03-18 2003-12-31 Pliva D D ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A
US6861413B2 (en) 2001-05-22 2005-03-01 Pfizer Inc. Stable non-dihydrate azithromycin oral suspensions
BR0209918A (pt) 2001-05-22 2004-03-30 Pfizer Prod Inc Formas cristalinas da azitromicina
GB0214277D0 (en) * 2002-06-20 2002-07-31 Biochemie Gmbh Organic compounds
US6855813B2 (en) 2002-07-19 2005-02-15 Alembic Limited Process for the preparation of azithromycin monohydrate
HRP20020614A2 (en) 2002-07-22 2004-06-30 PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o. Rhombic pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a
GB0224197D0 (en) * 2002-10-17 2002-11-27 Biochemie Gmbh Organic compounds
US20040266997A1 (en) * 2003-03-25 2004-12-30 Michael Pesachovich Degradation products of azithromycin, and methods for their indentification
US20050101547A1 (en) * 2003-11-06 2005-05-12 Sadatrezaei Mohsen Stabilized azithromycin composition
US7943585B2 (en) 2003-12-22 2011-05-17 Sandoz, Inc. Extended release antibiotic composition
US7384921B2 (en) 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7683162B2 (en) * 2004-08-30 2010-03-23 Taro Pharmaceutical Industries Limited Process of preparing a crystalline azithromycin monohydrate
JP4471941B2 (ja) * 2005-03-10 2010-06-02 山一電機株式会社 半導体装置用ソケット
US20090318375A1 (en) * 2005-06-08 2009-12-24 Hanmi Pharm Co., Ltd Crystalline Azithromycin L-Malate Monohydrate and Pharmaceutical Composition Containing Same
JP2012520268A (ja) 2009-03-13 2012-09-06 ダ・ボルテラ グラム陰性細菌の除去のための組成物及び方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU43006B (en) 1981-03-06 1989-02-28 Pliva Pharm & Chem Works Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
US4474768A (en) 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
RU2066324C1 (ru) * 1987-07-09 1996-09-10 Пфайзер Инк. Кристаллический дигидрат азитромицина и способ его получения
WO1989002271A1 (en) * 1987-09-10 1989-03-23 Pfizer Azithromycin and derivatives as antiprotozoal agents
PT102006B (pt) * 1997-05-19 2000-06-30 Hovione Sociedade Quimica S A Novo processo de preparacao de azitromicina
PT102130A (pt) * 1998-03-13 1999-09-30 Hovione Sociedade Quimica S A Processo de preparacao de dihidrato de azitromicina
CA2245398C (en) 1998-08-21 2002-01-29 Apotex Inc. Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof
CZ20011886A3 (cs) * 1998-11-30 2001-10-17 Teva Pharmaceutical Industries Ltd. Etanolát azitromycinu, postup přípravy a jeho farmaceutické preparáty
DE20023815U1 (de) 1999-06-29 2006-06-08 Sandoz Ag Azithromycin enthaltende Zusammensetzungen
ES2177373B1 (es) * 1999-11-26 2003-11-01 Astur Pharma Sa Preparacion de azitromicina en su forma no cristalina

Also Published As

Publication number Publication date
NO324951B1 (no) 2008-01-14
CZ303343B6 (cs) 2012-08-08
CA2429639C (en) 2009-07-14
KR20030055305A (ko) 2003-07-02
US6949519B2 (en) 2005-09-27
NO20032371L (no) 2003-07-10
HU229488B1 (hu) 2014-01-28
WO2002042315A3 (en) 2002-10-31
US20040053862A1 (en) 2004-03-18
BG66200B1 (bg) 2012-01-31
SK287814B6 (sk) 2011-11-04
CA2429639A1 (en) 2002-05-30
AU2002221895A1 (en) 2002-06-03
HUP0302099A3 (en) 2009-08-28
JP2004519430A (ja) 2004-07-02
CZ20031439A3 (cs) 2003-10-15
HRP20030430A2 (en) 2005-04-30
EP1339730A2 (en) 2003-09-03
SK6352003A3 (en) 2003-11-04
EE05200B1 (et) 2009-08-17
WO2002042315A2 (en) 2002-05-30
PL361276A1 (en) 2004-10-04
HRP20030430B1 (hr) 2011-11-30
PL207076B1 (pl) 2010-10-29
HUP0302099A2 (hu) 2003-10-28
KR100815163B1 (ko) 2008-03-19
EE200300255A (et) 2003-08-15
BG107832A (bg) 2004-07-30

Similar Documents

Publication Publication Date Title
ATE290000T1 (de) Muscarinagonisten
ATE252099T1 (de) Biarylcarboxamide
DE10136334B8 (de) Hochgeschwindigkeitsvertikalresonatoroberflächenemissionslaser
DE60138702D1 (de) 2-aminocarbonyl-9h-purinderivative
ATA2932001A (de) Schneefräse
DE50106867D1 (de) Kugelgelenk
DE50108226D1 (de) Vordralldüsenträger
DE50104056D1 (de) Gewichtsmanschette
DE50100710D1 (de) Wischblatt
ATE262530T1 (de) Indolochinazolinone
ATE298751T1 (de) 7-oxopyridoryrimidine
DE50104651D1 (de) Fahrzeugfaltverdeck
NO20032371D0 (no) Makrolidsolvater
AR028336A1 (es) 4-hidroxi-tetrahidropiridonas fenilsubstituidas
DE10192638T1 (de) Bohrstangenladevorrichtung
ATE509008T1 (de) Sulfonylguanidine
DE10196064T1 (de) Halbleiterfotodektionsgerät
ATE476423T1 (de) Benzoylpyridazine
DE50007634D1 (de) Kardioplegieballonkatheter
DE10052925B4 (de) Schaukelbett
DE10195909T1 (de) Viehfüttervorrichtung
DE10085445T1 (de) Drahterodierbearbeitungseinrichtung
AR027982A1 (es) Aril- y heteroarilsulfonatos
DE10195992T1 (de) Oberflächenendbearbeitungsbelag
DE60134767D1 (de) Ungsisolierung

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees